Effectiveness of Bi-Sai-Tong solution for moderate to severe allergic rhinitis: a randomized controlled study
Not Applicable
Recruiting
- Conditions
- allergic rhinitis
- Registration Number
- ITMCTR1900002527
- Lead Sponsor
- Guangdong Provincial Hospital of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Aged 18 to 65 years, both men and women;
2. Accorded with allergic rhinitis diagnostic criteria;
3. moderate-severe allergic rhinitis;
4. RQLQ scores >= 42 points
5. Patients signed informed consent.
Exclusion Criteria
1. Patients with moderate-severe deviation of nasal septum, sinusitis, rhinopolyp, nasopharynx cancer and other severe nasal diseases;
2. Patients with serious heart,liver,lung,kidney and blood system diseases;
3. Patients with unstable asthma control;
4. Psychiatric patients;
5. Those who are in on-going trial or ready to attend other clinical trials;
6. Allergic to the traditional Chinese medicine ingredients contained in the treatment drug;
7. Women during pregnant stage and breast-feed stage.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rhinoconjunctivitis Quality of Life Questionnaire, RQLQ;
- Secondary Outcome Measures
Name Time Method Frequency and dosage of medicine;ECP;Inhaled allergen test;Rhinitis exacerbation days;Visual Analogue Score, VAS;Questionnaire of nose and eyes;